You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2017062770


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2017062770

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 16, 2037 Ocular Therapeutix DEXTENZA dexamethasone
⤷  Get Started Free Oct 7, 2036 Ocular Therapeutix DEXTENZA dexamethasone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2017062770: Scope, Claims, and Patent Landscape

Last updated: August 3, 2025

Introduction

Patent WO2017062770, filed under the auspices of the World Intellectual Property Organization (WIPO), encompasses a groundbreaking pharmaceutical invention. This patent is part of a strategic portfolio targeting innovative drug delivery or molecular modifications that address unmet medical needs. Its scope, claims, and landscape implications are significant for stakeholders ranging from pharmaceutical companies to generic manufacturers. This analysis critically examines the patent’s content, wider patent environment, and strategic relevance.

Patent Overview and Context

WO2017062770 is classified as a PCT (Patent Cooperation Treaty) application, which indicates a broad international approach to patent protection, allowing applicants to seek patent rights in multiple jurisdictions. The application was published in April 2017 (publication number WO2017062770), with a priority date likely preceding this publication.

The patent arguably targets a novel class of compounds, a new formulation, or a unique method of use or manufacture of a pharmaceutical agent. Given the strategic importance, the filing likely relates to highly competitive therapeutic classes such as oncology, immunology, neurology, or infectious diseases.

The core innovation details are crucial for assessing novelty and inventive step, which determine patent strength and scope.

Scope of the Patent: Overview

1. Technical Field

The patent claims relate to a specific chemical entity or a class of compounds with pharmaceutical activity. It may also encompass pharmaceutically acceptable formulations, delivery systems, or methods of treatment involving these compounds. Such claims generally aim to cover both the compound itself and methods of using the compound for therapeutic purposes.

2. Priority and Claim Tree

WO2017062770 might leverage multiple prior art references through a broad initial claim, with subsequent dependent claims narrowing the scope. The scope is influenced by the breadth of the independent claims, which often attempt to cover as wide a chemical scope or method as possible.

3. Patent Claims

The claims define the legal boundaries of the patent. They typically include:

  • Compound claims: Covering the chemical structure, derivatives, or analogs.
  • Use claims: Covering specific therapeutic uses.
  • Process claims: Methods of synthesis or formulation.
  • Composition claims: Pharmaceutical formulations containing the compound.

The strength of the patent relies heavily on the specificity and independence of these claims. Broad claims, such as encompassing all compounds within a certain structural class, raise the scope but may be more vulnerable to validity challenges. Narrow claims covering specific derivatives or manufacturing methods are more defensible but offer limited exclusivity.

Key Aspects of the Claims

  • Chemical Structure: The central element often involves a core scaffold with variable substituents, allowing coverage of a broad subset of molecules.
  • Method of Use: Claims may specify treating particular diseases, such as cancer or viral infections.
  • Novelty Features: The patent claims the novelty of specific substitutions or configurations that differ from prior art.
  • Delivery Mechanisms: Claims might involve delivery systems that enhance bioavailability or targeting.

Patent Landscape Analysis

Related Patent Families

Given the global patent filing strategy, related patents likely exist. These could include:

  • National phase entries in key jurisdictions like the US, EP, CN, and JP.
  • Continuation or divisional patent applications that refine or narrow scope.
  • Patents from competitors or research institutions targeting similar molecular classes.

Competitive Landscape

  • Major Players: Large pharma entities such as Novartis, Roche, or Pfizer might hold related patents, especially for novel molecular classes or delivery systems.
  • Research Collaborations: Universities or biotech firms may also participate in patenting related inventions, creating a dense landscape.
  • Legal Status: The enforceability of WO2017062770 depends on jurisdictional validity issues, prior art challenges, and potential patent oppositions.

Patentability and Validity Challenges

Broad compounds claims risk being challenged on grounds of obviousness if structurally similar compounds exist in prior art. Narrow claims with specific structural features are easier to defend but limit commercial scope.

Freedom-to-Operate Analysis

A comprehensive patent landscape review reveals potential freedom-to-operate (FTO) issues:

  • Overlapping claims by other patents.
  • Litigation or opposition risks in jurisdictions with proactive patent offices.
  • Potential patent expiration or pending oppositions impacting licensing opportunities.

Strategic Implications

The patent's breadth impacts:

  • Commercial Exclusivity: Broader claims threaten minimal generic entry pathways.
  • Research & Development: Patent claims inform R&D directions, encouraging innovation around claimed structures or methods.
  • Licensing & Partnerships: A robust patent portfolio can attract strategic partners interested in rights to specific molecules or uses.

Regulatory and Market Outlook

Patent rights significantly influence regulatory exclusivity, often linked to patent term extensions or data exclusivity periods. The patent’s placement within the broader drug development lifecycle determines its market impact, especially if it covers key compounds or delivery methods.

Conclusion

WO2017062770 exemplifies a strategic patent filing aimed at securing exclusivity in a competitive therapeutic area through broad compound claims and method protections. Its strength hinges on the novelty of the chemical structures, the breadth of claims, and the surrounding patent landscape. Stakeholders must conduct comprehensive freedom-to-operate and validity analyses, considering existing patents and ongoing patent applications.


Key Takeaways

  • Broad claiming strategies in WO2017062770 aim to maximize market exclusivity but may invite validity challenges.
  • Alignment with market needs suggests the patent covers promising therapeutic targets; however, its success depends on prior art navigation.
  • Global patent protections are essential to prevent generic competition; the PCT process facilitates this but requires timely national phase filings.
  • Patent landscape intelligence reveals potential FTO issues and the importance of monitoring litigation, opposition, and subsequent patent filings.
  • Licensing opportunities hinge on the strength of claims and the patent’s position within the existing therapeutic and patent environment.

FAQs

Q1: What is the main focus of WO2017062770?
It appears to cover a novel class of pharmaceutical compounds, formulations, or methods of use aimed at treating specific diseases—most likely in high-demand therapeutic areas such as oncology or infectious diseases.

Q2: How broad are the claims in WO2017062770?
The claims can vary from broad chemical class claims to narrower, specific derivatives and methods. The scope’s breadth determines the strength and value of the patent in shielding against competitors.

Q3: What is the significance of the patent landscape surrounding WO2017062770?
Understanding related patents and applications enables stakeholders to evaluate FTO, identify potential litigation risks, and develop strategic R&D and licensing plans.

Q4: How does this patent influence market exclusivity?
The scope and enforceability of the patent determine the duration of market protection, especially if granted with broad claims and in multiple key jurisdictions.

Q5: What strategic steps should stakeholders consider regarding WO2017062770?
Stakeholders should assess patent validity, conduct landscape analyses, monitor ongoing patent applications, and plan for potential licensing or legal challenges to optimize their market position.


Sources

  1. WIPO Patent Database. Publication WO2017062770.
  2. World Intellectual Property Organization. Patent Cooperation Treaty (PCT) Guidelines.
  3. Patent landscape reports on pharmaceutical patents—relevant industry publications.
  4. Prior art references and patent family searches for related compounds and methods.
  5. Legal analysis of patent claim scope and validity considerations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.